State of Wisconsin Investment Board’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

State of Wisconsin Investment Board’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,400	Closed	-$2.03M	–	2121
2020 Q4	$2.03M	Sell	15,400 -1,900	-11%	-$168K	﹤0.01%	1200
2020 Q3	$874K	Hold	17,300	–	–	﹤0.01%	1320
2020 Q2	$825K	Hold	17,300	–	–	﹤0.01%	1281
2020 Q1	$848K	Sell	17,300 -6,400	-27%	-$326K	﹤0.01%	1231
2019 Q4	$1.36M	Hold	23,700	–	–	﹤0.01%	1183
2019 Q3	$852K	Hold	23,700	–	–	﹤0.01%	1178
2019 Q2	$737K	Buy	23,700 +13,800	+139%	+$374K	﹤0.01%	1222
2019 Q1	$232K	Buy	+9,900	New	+$159K	﹤0.01%	1446

State of Wisconsin Investment Board's EIDX Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 15,400 shares — an estimated $2.03M sold.

State of Wisconsin Investment Board first reported a position in EIDX in Q1 2019 and held it in 8 quarters. The position peaked at $2.03M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

State of Wisconsin Investment Board reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 15,400 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $2.03M.
State of Wisconsin Investment Board first reported a position in Eidos Therapeutics, Inc. Common Stock in Q1 2019 and held it in 8 quarters.
State of Wisconsin Investment Board's Eidos Therapeutics, Inc. Common Stock position peaked at $2.03M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.